Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States.

We report on the first Neisseria gonorrhoeae isolate in the United States identified with high-level resistance to azithromycin. This report discusses the epidemiologic case investigation, the molecular studies of resistance-associated mutations and N. gonorrhoeae multiantigen sequence typing, and challenges posed by emerging gonococcal antimicrobial resistance.

[1]  Makoto Ohnishi,et al.  Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan , 2011, Emerging infectious diseases.

[2]  Stuart Berman,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[3]  C. Lowndes,et al.  European surveillance of antimicrobial resistance in Neisseria gonorrhoeae , 2010, Sexually Transmitted Infections.

[4]  S. Chisholm,et al.  High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes , 2010, Antimicrobial Agents and Chemotherapy.

[5]  J. Vázquez,et al.  New Mutation in 23S rRNA Gene Associated with High Level of Azithromycin Resistance in Neisseria gonorrhoeae , 2010, Antimicrobial Agents and Chemotherapy.

[6]  J. Vázquez,et al.  Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. , 2009, Sexually transmitted diseases.

[7]  R. Howe,et al.  Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. , 2009, The Journal of antimicrobial chemotherapy.

[8]  P. Stefanelli,et al.  Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. , 2009, The Journal of antimicrobial chemotherapy.

[9]  H. Palmer,et al.  Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. , 2008, The Journal of antimicrobial chemotherapy.

[10]  Kevin A Fenton,et al.  Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. , 2004, The Journal of infectious diseases.

[11]  M. V. Lee,et al.  Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  W. Whittington,et al.  Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. , 2003, The Journal of antimicrobial chemotherapy.

[13]  L. Ng,et al.  Mutation in 23S rRNA Associated with Macrolide Resistance in Neisseria gonorrhoeae , 2002, Antimicrobial Agents and Chemotherapy.

[14]  W. Whittington,et al.  Identification of the Conjugative mefGene in Clinical Acinetobacter junii and Neisseria gonorrhoeae Isolates , 2000, Antimicrobial Agents and Chemotherapy.

[15]  D. E. Roe,et al.  Erythromycin-Resistant Neisseria gonorrhoeae and Oral Commensal Neisseria spp. Carry Known rRNA Methylase Genes , 1999, Antimicrobial Agents and Chemotherapy.

[16]  R. Ohye,et al.  Diversity of Isolates of Penicillinase‐Producing Neisseria gonorrhoeae (PPNG) in Honolulu, Hawaii: 1982–1991 , 1994, Sexually transmitted diseases.

[17]  R. Ohye,et al.  Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii , 1994, Antimicrobial Agents and Chemotherapy.

[18]  Gorwitz Rj,et al.  Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group. , 1993 .

[19]  A. Nakashima,et al.  Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group. , 1993, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.